S. A. Gregory

830 total citations
37 papers, 621 citations indexed

About

S. A. Gregory is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, S. A. Gregory has authored 37 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 12 papers in Pathology and Forensic Medicine and 10 papers in Genetics. Recurrent topics in S. A. Gregory's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (6 papers). S. A. Gregory is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Myeloid Leukemia Research (6 papers). S. A. Gregory collaborates with scholars based in United States, Germany and United Kingdom. S. A. Gregory's co-authors include Vera Markgraf, Henry F. Díaz, Lorenz Trümper, M. R. Albert, Ian Baker, Harvey D. Preisler, Suneel Mundle, Guitta Maki, William H. Knospe and Nathalie Rouas‐Freiss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

S. A. Gregory

34 papers receiving 591 citations

Peers

S. A. Gregory
C. Huber Austria
RL Edwards United States
M. D. Sweeney United States
Christian Schuster Germany
Philippe Courville France
SE Jones United Kingdom
Ganapati V. Hegde United States
Jos Rijntjes Netherlands
Philip J. Hoedemaeker Netherlands
John F. Stone United States
C. Huber Austria
S. A. Gregory
Citations per year, relative to S. A. Gregory S. A. Gregory (= 1×) peers C. Huber

Countries citing papers authored by S. A. Gregory

Since Specialization
Citations

This map shows the geographic impact of S. A. Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Gregory more than expected).

Fields of papers citing papers by S. A. Gregory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Gregory. The network helps show where S. A. Gregory may publish in the future.

Co-authorship network of co-authors of S. A. Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of S. A. Gregory. A scholar is included among the top collaborators of S. A. Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. A. Gregory. S. A. Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bühler, Andreas, Thomas J. Kipps, Laura Z. Rassenti, et al.. (2016). Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial. Blood Cancer Journal. 6(3). e404–e404. 11 indexed citations
2.
Gregory, S. A., M. R. Albert, & Ian Baker. (2014). Impact of physical properties and accumulation rate on pore close-off in layered firn. ˜The œcryosphere. 8(1). 91–105. 47 indexed citations
3.
Evens, Andrew M., Kenneth R. Carson, Jill Kolesar, et al.. (2013). A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma. Annals of Oncology. 24(12). 3076–3081. 35 indexed citations
4.
Karmali, Reem, S. A. Gregory, Jamile M. Shammo, et al.. (2011). Etoposide and cytarabine as an effective and safe cytoreductive regimen for relapsed or refractory acute myeloid leukemia.. Journal of Clinical Oncology. 29(15_suppl). 6539–6539.
5.
Maki, Guitta, Gregory M. Hayes, Abderrahim Naji, et al.. (2008). NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia. 22(5). 998–1006. 78 indexed citations
6.
Gregory, S. A., Parameswaran Venugopal, Jamile M. Shammo, et al.. (2007). Assessing the impact of comorbidities on autologous hematopoietic cell transplant (AHCT) outcomes using the hematopoietic cell transplant-comorbidity index (HCT-CI) in lymphoma. Journal of Clinical Oncology. 25(18_suppl). 7102–7102. 3 indexed citations
7.
Gehring, Stephan, et al.. (2006). KUPFFER CELLS ABROGATE CHOLESTATIC LIVER INJURY IN MICE. Journal of Pediatric Gastroenterology and Nutrition. 42(5).
8.
Gregory, S. A. & Lorenz Trümper. (2005). Chemotherapy dose intensity in non-Hodgkin's lymphoma: is dose intensity an emerging paradigm for better outcomes?. Annals of Oncology. 16(9). 1413–1424. 37 indexed citations
9.
Faderl, Stefan, Steven Coutré, John C. Byrd, et al.. (2005). The evolving role of Alemtuzumab in management of patients with CLL. Leukemia. 19(12). 2147–2152. 21 indexed citations
10.
11.
Vadhan‐Raj, Saroj, B. Mirtsching, S. A. Gregory, et al.. (2004). Baseline (BL) covariates of response to darbepoetin alfa (DA) every 2 weeks (Q2W) in patients (pts) with chemotherapy-induced anemia (CIA). Journal of Clinical Oncology. 22(14_suppl). 8061–8061. 5 indexed citations
12.
Vadhan‐Raj, Saroj, B. Mirtsching, S. A. Gregory, et al.. (2004). Baseline (BL) covariates of response to darbepoetin alfa (DA) every 2 weeks (Q2W) in patients (pts) with chemotherapy-induced anemia (CIA). Journal of Clinical Oncology. 22(14_suppl). 8061–8061. 1 indexed citations
13.
Hussein, M. A., et al.. (2004). Updated results from a randomized multicenter trial of DVd vs VAd in patients with newly diagnosed multiple myeloma. Journal of Clinical Oncology. 22(14_suppl). 6509–6509. 5 indexed citations
14.
Preisler, Harvey D., Parameswaran Venugopal, S. A. Gregory, et al.. (2001). High Remission Rate in Acute Myeloblastic Leukemia with Only Two Days of Chemotherapy. Leukemia & lymphoma. 41(3-4). 333–336. 4 indexed citations
15.
Ranganathan, Raghuveer, Xiao‐Jun Huang, Timothy O’Brien, et al.. (2000). Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?. Microscopy Research and Technique. 50(3). 251–257. 17 indexed citations
16.
Preisler, Harvey D., Parameswaran Venugopal, S. A. Gregory, et al.. (2000). Poor prognosis acute myelogenous leukemia: 1 – response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leukemia Research. 24(8). 671–680. 7 indexed citations
17.
Mundle, Suneel, Parameswaran Venugopal, V. Shetty, et al.. (1999). The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.. PubMed. 69(3). 152–9. 24 indexed citations
18.
Gregory, S. A. & George A. Maul. (1995). Climatic Change in the Intra-Americas Sea. Geographical Journal. 161(3). 328–328. 22 indexed citations
19.
Gregory, S. A., Henry F. Díaz, & Vera Markgraf. (1993). El Niño: Historical and Paleoclimatic Aspects of the Southern Oscillation. Geographical Journal. 159(3). 343–343. 68 indexed citations
20.
Knospe, William H., et al.. (1970). Effect of a noncellular spleen-derived factor on recovery of hematopoietic stem cells from irradiation.. PubMed. 76(4). 584–92. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Huber Breakdown of academic impact, for papers by RL Edwards Breakdown of academic impact, for papers by M. D. Sweeney Breakdown of academic impact, for papers by Christian Schuster Breakdown of academic impact, for papers by Philippe Courville Breakdown of academic impact, for papers by SE Jones Breakdown of academic impact, for papers by Ganapati V. Hegde Breakdown of academic impact, for papers by Jos Rijntjes Breakdown of academic impact, for papers by Philip J. Hoedemaeker Breakdown of academic impact, for papers by John F. Stone
Rankless by CCL
2026